What Causes Dark Circles Under Your Eyes — and the Right Treatment for Each

Infraorbital dark circles—clinically termed periorbital hyperpigmentation, infraorbital shadowing, or periorbital melanosis—are among the most common complaints in aesthetic dermatology. Patients frequently report that they look tired, aged, or unwell, regardless of their sleep patterns or lifestyle habits.

A common clinical failure is treating all dark circles with a single modality, such as dermal fillers or topical brightening creams. In practice, dark circles have several distinct etiologies. Applying dermal filler to pigment-based circles can worsen their appearance through the Tyndall effect, while applying brightening creams to a deep structural hollow is financially wasteful and clinically ineffective.

This guide provides a clinical framework for diagnosing the root cause of your dark circles and matching it to the appropriate treatment. We cover the four primary etiologies, the diagnostic tests you can perform at home, treatment pathways (including hyaluronic acid fillers, platelet-rich fibrin, polynucleotides, and lasers), skin-of-color safety guidelines, and real-world safety data from the FDA's databases.

---

The Core Diagnostics Above the Fold

Before embarking on any treatment path, you must identify the primary driver of your dark circles.

• Pigment-based circles (Melanin): Caused by excess melanin in the skin. They appear brown or black and are highly common in Fitzpatrick skin types IV–VI. They respond best to topical tyrosinase inhibitors, chemical peels, and non-ablative picosecond lasers.
• Vascular-based circles (Blood Vessels): Caused by thin, translucent lower-eyelid skin showing the underlying orbicularis oculi muscle and capillaries. They appear blue, purple, or red and worsen with vascular congestion. They respond to vascular lasers (PDL, Nd:YAG) and skin-thickening agents.
• Structural-based circles (Hollows/Shadows): Caused by volume loss in the tear-trough region, fat-pad descent, or orbital fat-pad bulging (under-eye bags). They appear as shadows that shift depending on the angle of overhead lighting. They respond to tear trough fillers, regenerative autologous injectables, or surgical blepharoplasty.
• Mixed-type circles: A combination of two or more of the above etiologies, requiring a stacked or multi-modal treatment plan.

---

Etiology and Pathophysiology of Infraorbital Dark Circles

To understand why treatments must be customized, we must examine the micro-anatomy of the periorbital region. The skin of the lower eyelid is the thinnest on the human body, measuring approximately 0.5 mm in thickness compared to 1.0–2.0 mm on other parts of the face. This makes the underlying structures highly visible.

1. Hyperpigmentation (Pigment-Based Etiology)

Hyperpigmentation is driven by increased melanin deposition in the epidermis or dermis of the periorbital skin. This can be caused by:

• Genetic Predisposition: Constitutional hyperpigmentation, frequently seen in patients of Mediterranean, Middle Eastern, Asian, or African descent.
• Post-Inflammatory Hyperpigmentation (PIH): Triggered by chronic rubbing due to allergic contact dermatitis, atopic dermatitis, or seasonal rhinoconjunctivitis.
• Dermal Melanocytosis: The presence of melanocytes deep in the dermis, giving a grey-blue tint that is highly resistant to superficial topical treatments.

2. Vascular Congestion and Translucency (Vascular-Based Etiology)

Vascular dark circles occur when the capillary network, subcutaneous veins, or the underlying orbicularis oculi muscle show through the thin, translucent lower-eyelid skin.

• Thin Skin: As we age, dermal collagen and elastin degrade, making the skin thinner and increasing the visibility of the underlying vascular bed.
• Venous Stasis: Allergic rhinitis or sleep deprivation causes congestion in the nasal and periorbital veins. This slows blood flow, leading to deoxygenated blood pooling in the infraorbital region, which appears as a dark blue or purple tint.

3. Tear-Trough Hollowing and Shadowing (Structural-Based Etiology)

Structural dark circles are not caused by color changes in the skin itself, but by shadows cast by facial anatomy under overhead lighting.

• Tear-Trough Deformity: The tear trough is a natural depression running from the inner corner of the eye down toward the cheek. It is bound by the tear-trough ligament (orbicularis retaining ligament) to the maxilla.
• Age-Related Volume Loss: With age, the maxilla bone resorbs, the deep malar fat pad deflates, and the overlying skin loses elasticity. This deepens the tear-trough hollow, casting a prominent shadow.
• Orbital Fat Protrusion: The orbital septum weakens over time, allowing the fat pads surrounding the eye to bulge forward. This bulging (under-eye bags) casts a deep shadow directly beneath it, mimicking dark circles. It is critical to distinguish "bags" from "circles," as bags often require surgical correction; for a detailed guide on this choice, see our analysis of bags under the eyes: filler vs blepharoplasty.

---

How to Diagnose Your Root Cause at Home: The Diagnostics

Before visiting a dermatologist, you can narrow down your etiology using two simple diagnostic tests.

Test 1: The Pinch Test

Gently pinch the skin of your lower eyelid between your thumb and forefinger and pull it slightly away from the face.

• If the dark color moves with the skin and remains dark when pinched: Your dark circles are primarily pigment-based. The melanin is bound within the epidermal or dermal layers.
• If the color does not move, fades, or changes tint when the skin is stretched: Your dark circles are primarily vascular-based. Stretching the skin temporarily displaces the underlying blood vessels or changes the light refraction through the tissue.
• If the color disappears completely when you lift the skin or lie flat with a mirror: Your dark circles are structural. Lifting the skin or lying flat eliminates the shadow cast by the hollow or fat pad.

Test 2: The Lighting Test

Look at yourself in a mirror under direct overhead lighting (such as a bathroom light), then tilt your head back to look at the ceiling.

• If the circles remain unchanged: You have pigment or vascular circles.
• If the dark shadow disappears or improves dramatically when your head is tilted back: You have structural tear-trough hollowing. The change in light angle eliminates the shadow.

---

The Cause-to-Treatment Routing Matrix

Using the results of your diagnostics, you can map your etiology to the appropriate clinical treatments.

---

Skin of Color and Fitzpatrick Safety: Guardrails for Pigment-Based Circles

Patients with Fitzpatrick skin types IV–VI (skin of color) require a cautious approach when treating pigment-based dark circles. Their melanocytes are highly active and reactive.

The Risk of Post-Inflammatory Hyperpigmentation (PIH)

Any treatment that causes excessive heat, inflammation, or epidermal disruption can trigger a rebound reaction, where reactive melanocytes produce excess melanin. This leads to post-inflammatory hyperpigmentation (PIH), making the dark circles significantly darker than their original baseline.

• High-Risk Treatments:
  • Ablative Lasers (CO2, Erbium:YAG): High risk of PIH and scarring in dark skin.
  • Aggressive Chemical Peels: High-concentration glycolic acid or TCA peels can cause epidermal sloughing and subsequent PIH.
  • Intense Pulsed Light (IPL): Hard to control depth and absorption in melanin-rich skin, risking localized skin burns.
• First-Line Skin-of-Color Protocol:
  1. Topical Tyrosinase Inhibitors: Hydroquinone (2% to 4% cycled for 3 months), azelaic acid (15% to 20%), kojic acid, tranexamic acid, and licorice root extract. These ingredients downregulate melanin production without damaging melanocytes.
  2. Strict Photoprotection: Broad-spectrum mineral sunscreen (zinc oxide/titanium dioxide) with iron oxides. Iron oxides protect against blue light (visible light), which is known to drive persistent hyperpigmentation in darker skin.
  3. Low-Heat Picosecond Lasers: Pico-fractional lasers deliver energy in trillionths of a second. This relies on acoustic shockwaves (photomechanical effect) rather than heat (photothermal effect) to shatter dermal pigment, minimizing PIH risk.

---

Vascular Lasers: Targeting the Red and Blue Beds

When dark circles are driven by visible capillaries or venous congestion, topical creams offer limited relief. Dermatologists turn to targeted vascular lasers that utilize the principle of selective photothermolysis to destroy superficial vessels without damaging the surrounding skin.

Physics of Vascular Lasers

Vascular lasers target the chromophore oxyhemoglobin (found in red blood cells) and deoxyhemoglobin (found in blue-purple venous blood). The laser energy is absorbed by the blood, converting to heat and causing thermal damage to the vessel wall, leading to vessel closure (coagulation) and subsequent resorption by the body.

1. Pulsed Dye Laser (PDL - 595 nm): Brand names like Vbeam. The 595 nm wavelength is highly absorbed by oxyhemoglobin. It is ideal for superficial, fine red capillaries. Pulse durations are kept brief to match the thermal relaxation time of the small vessels.
2. Nd:YAG Laser (1064 nm): Nd:YAG lasers penetrate deeper into the dermis. The 1064 nm wavelength is absorbed by both oxyhemoglobin and deoxyhemoglobin, making it highly effective for deeper, larger blue-purple infraorbital veins.
3. KTP Laser (532 nm): Brand names like Excel V. This green light wavelength is extremely absorbed by hemoglobin, making it highly effective for very superficial red vessels, though it carries a higher risk of epidermal thermal injury in darker skin.

Post-Laser Recovery and Parameters

• Purpura (Bruising): PDL treatments can cause localized bruising (purpura) that lasts for 3 to 10 days. Providers can adjust pulse durations to a "sub-purpuric" setting to prevent bruising, though this may require more sessions.
• Session Count: Typically 3 to 5 sessions spaced 4 weeks apart.
• Risk Mitigation: The eye globe must be protected with internal metal eye shields (inserted after applying numbing drops) when treating inside the orbital rim.

---

Chemical Peels for Periorbital Hyperpigmentation

Chemical peels exfoliate the outer layers of the skin, accelerating epidermal turnover and removing accumulated melanin. However, the delicate under-eye area requires specialized peel selections and protocols.

Active Ingredients and Concentrations

• Lactic Acid (10% to 30%): An alpha-hydroxy acid (AHA) derived from sour milk. It is the gentlest peel option and possesses natural humectant properties, drawing moisture into the skin while gently exfoliating. Excellent for mild pigment and skin dehydration.
• Mandelic Acid (20% to 40%): A larger-molecule AHA derived from bitter almonds. It penetrates the skin slowly and evenly, making it exceptionally safe for Fitzpatrick IV–VI skin types with minimal risk of irritation or PIH.
• Glycolic Acid (20% to 35%): A small-molecule AHA that penetrates rapidly. It must be carefully timed and fully neutralized with sodium bicarbonate to prevent deep penetration and chemical burns.
• Trichloroacetic Acid (TCA - 10% to 15%): A self-neutralizing medium-depth peel. It should only be used in low concentrations in the periorbital region. It causes protein coagulation (frosting), leading to visible peeling over 5 to 7 days.

Clinical Protocol and Eye Safety

1. Prep: The skin is cleansed and degreased with alcohol or acetone.
2. Protection: A barrier ointment, such as petrolatum, is applied to the outer and inner corners of the eyes and the lid margin to prevent the acid from pooling or entering the eye.
3. Application: The peel solution is applied using a cotton-tipped applicator, keeping at least 2 to 3 mm away from the eyelash margin.
4. Neutralization: If using non-self-neutralizing acids (like glycolic), the solution is neutralized immediately if erythema (redness) occurs or if the patient reports a burning sensation above a 3/10.

---

Systemic Health and Lifestyle Factors

In some cases, dark circles are not merely dermatological but serve as cutaneouos indicators of systemic health changes.

1. Vascular Congestion and Airway Obstruction

Chronic nasal airway resistance—driven by a deviated septum, nasal polyps, or obstructive sleep apnea (OSA)—causes blood backup in the cavernous sinus and nasal mucosa. This venous stasis extends to the angular and infraorbital veins. As deoxygenated blood pools, it shows through the thin lower eyelid skin. Addressing the airway obstruction or using a CPAP machine often leads to a marked reduction in vascular-type dark circles.

2. Anemia and Tissue Hypoxia

Iron-deficiency anemia leads to reduced levels of hemoglobin, the oxygen-carrying protein in red blood cells. Insufficient oxygenation of periorbital tissues causes the blood to appear darker and more bluish, making the vascular bed beneath the eyes more prominent. Supplementing with iron (under medical supervision) can correct the tissue hypoxia and improve skin color.

3. Cortisol and Sleep Deprivation

Chronic stress elevates systemic cortisol levels. High cortisol levels break down dermal collagen, thinning the skin and increasing vessel visibility. Furthermore, sleep deprivation triggers vasoconstriction of peripheral blood vessels but dilates central vessels (including periorbital veins), worsening venous pooling.

---

Dermal Fillers, PRF, and Polynucleotides: Restoring Volume

For structural hollows, restoring volume is the only way to eliminate the shadow. Patients today have three primary options: traditional hyaluronic acid (HA) fillers, autologous platelet-rich fibrin (PRF), and emerging polynucleotides.

1. Hyaluronic Acid (HA) Dermal Fillers

HA fillers (such as Restylane L or Juvéderm Volbella) are the clinical standard for tear-trough restoration. They provide immediate projection, smoothing the transition between the lower eyelid and the cheek.

• Longevity: 9 to 18 months, often lasting longer in the under-eye area due to minimal muscle movement.
• Reversibility: Fully reversible with the injection of hyaluronidase, providing a safety net if complications arise.
• Key Risks:
  • The Tyndall Effect: If HA filler is injected too superficially (above the orbicularis oculi muscle), light scattering through the clear gel gives the skin a bluish, bruised appearance. This can be mistaken for worsening dark circles.
  • Delayed Swelling/Edema: HA is hydrophilic, attracting water. Over time, some fillers can absorb excess water, leading to chronic morning puffiness under the eyes.

2. Platelet-Rich Fibrin (PRF) and PRF EZ Gel

PRF is an autologous treatment prepared by spinning the patient's blood in a centrifuge at low speeds. This preserves a high concentration of platelets, white blood cells, and fibrin, along with active growth factors. Tear trough filler vs PRF EZ gel is a common clinical choice for patients seeking natural tissue regeneration over synthetic volume.

• Mechanism: When injected, PRF forms a natural fibrin scaffold that slowly releases growth factors over 7 to 10 days. This stimulates angiogenesis (new blood vessel growth) and neocollagenesis (new collagen synthesis) to thicken the skin and improve contour.
• EZ Gel: Heating a portion of the PRF denatures the proteins, forming a natural gel that provides temporary structural volume similar to a filler, but without synthetic chemicals.
• Advantage: Zero risk of Tyndall effect or allergic reaction, and a lower risk of delayed edema.
• Disadvantage: Requires a blood draw and multiple sessions (usually 3 sessions spaced 4 weeks apart) for optimal results, and the volume effect is less predictable than HA filler.

3. Polynucleotides (PDRN)

Polynucleotides (specifically polymerised polynucleotides, like Plinest or Nucleofill) represent the latest class of regenerative injectables. Derived from purified salmon DNA, they function as biostimulators rather than fillers.

• Mechanism: Polynucleotides bind to adenosine A2A receptors on fibroblasts. This stimulates cell division, collagen synthesis, and elastic fiber production, while promoting tissue hydration and reducing inflammation.
• Clinical Fit: Ideal for patients with crepy skin, mild hollowing, and vascular translucency. By thickening the dermis, polynucleotides help cover the underlying dark vascular bed. For a deep dive into this technology, read our guide on polynucleotides for skin rejuvenation.

---

Safety and Adverse Event Analysis: What the FDA Database Shows

Because the under-eye area is highly vascular and anatomically complex, safety is a primary consideration. Under-eye injections carry a rare but severe risk of vascular occlusion, which can lead to skin necrosis or permanent blindness if filler enters the ophthalmic artery.

FDA MAUDE Database Analysis

To evaluate the real-world safety of under-eye injections, we performed a query of the FDA's Manufacturer and User Facility Device Experience (MAUDE) database. We searched for adverse event reports containing the terms "tear" or "trough" in the events summary.

The search returned 44 matching rows in the database.

[!IMPORTANT] A critical examination of these 44 rows reveals a significant reporting caveat that highlights the need for manual data validation.

• The Search Results: While the query was designed to isolate under-eye filler complications, 28 of the 44 rows were associated with product code FTR (Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled) and 2 rows with product code FWM (Prosthesis, Breast, Inflatable, Internal, Saline). These reports actually referred to "teardrop-shaped" silicone or saline breast implants (e.g. Corning, Surgitek, or McGhan teardrop implants) that had ruptured, rotated, or caused localized tissue changes.
• The Lipoplasty System Matches: 13 rows were linked to product code MUU (System, Suction, Lipoplasty), referring to suction tubes or cannulas that had torn or broken during fat harvesting.
• Remaining Match: The single remaining row carried a non-filler product code and was unrelated to periorbital treatment. In other words, a literal term search of the summary fields surfaces essentially zero clean tear-trough filler complications — the real filler-event narrative lives in separate unstructured text files that the summary omits.

The Clinical Takeaway

While the raw database search yields a small count of directly matching tear-trough filler events under the literal search parameters, it is critical to note that the MAUDE database's summary fields often omit detailed narrative text (which is stored in separate, unstructured files). The actual incidence of filler-related complications, such as nodule formation, Tyndall effect, and migration, is significantly higher but frequently managed in-clinic without a formal report to the manufacturer or the FDA.

Vascular occlusion that propagates into the ophthalmic artery and causes blindness is rare but well documented in the aesthetic literature, and the periorbital region is among the highest-risk injection sites — which is why this risk dictates injection technique rather than being dismissed. To mitigate this risk, providers must:

1. Use a blunt-tipped cannula (typically 25G or 27G) instead of a sharp needle for under-eye injections, as cannulas are less likely to puncture blood vessels.
2. Inject slowly and with minimal pressure.
3. Have a hyaluronidase emergency kit immediately available on-site to dissolve HA filler if pain, blanching (whitening of the skin), or vision changes occur.

---

Daily Skincare Integration: Active Ingredients and Routines

For pigment and vascular circles, a daily skincare routine is a critical baseline. We present a structured skincare protocol designed to downregulate melanin and support the dermal matrix.

Example Daily Skincare Protocol

---

Decision Flow: Selecting Your Treatment Path

To choose the right path for your dark circles, follow this clinical decision tree:

               Determine the Best Under-Eye Treatment
                                 │
         ┌───────────────────────┼───────────────────────┐
         ▼                       ▼                       ▼
   Is it Pigment?          Is it a Hollow?         Is it Vascular?
         │                       │                       │
   ┌─────┴─────┐           ┌─────┴─────┐                 ▼
   ▼           ▼           ▼           ▼            Thicken Skin
Skin Type   Skin Type   Synthetic   Natural/     (Retinol, Vascular
  I-III       IV-VI      Volume    Regenerative   lasers like Vbeam)
   │           │           │           │
   ▼           ▼           ▼           ▼
 Chemical    Topical    HA Filler   PRF or
  Peels,    Brighteners, (Restylane) Polynucleotides
Q-Switch/    Pico Laser
Pico Laser

---

Frequently Asked Questions

Can lack of sleep cause dark circles, or is that a myth?

Lack of sleep does not create permanent dark circles, but it worsens their appearance. Sleep deprivation causes venous congestion (blood pooling) under the eyes, which shows through the thin skin as a dark blue or purple tint. It also causes fluid retention and systemic dehydration, which can deepen structural hollows and make shadows more pronounced.

Are dark circles permanent?

Constitutional (genetic) dark circles are generally permanent but can be managed and improved with ongoing treatment. Dark circles caused by temporary factors—such as seasonal allergies, sleep deprivation, or hyperpigmentation from rubbing—often resolve completely once the underlying cause is addressed.

Which dark-circle treatment is safest for skin of color?

The safest treatments are topical tyrosinase inhibitors (azelaic acid, tranexamic acid, cycled hydroquinone), gentle chemical peels (like lactic acid or mandelic acid), and low-heat picosecond lasers. High-heat lasers and deep chemical peels should be avoided due to the high risk of post-inflammatory hyperpigmentation.

How long does under-eye filler last for dark circles?

Hyaluronic acid fillers in the tear trough typically last 9 to 18 months. Because there is very little muscle movement in the under-eye area compared to the lips or nasolabial folds, the filler degrades slowly. Some patients report visible volume retention up to two years post-injection.

Can allergy shots or antihistamines cure vascular dark circles?

Yes, if the vascular dark circles are driven by "allergic shiners." Antihistamines and allergy immunotherapy reduce inflammation and nasal congestion, which relieves venous stasis in the nasal and periorbital veins. This allows pooled, deoxygenated blood to flow normally, resolving the dark tint.

What are the warning signs of vascular occlusion during under-eye filler injection?

If filler enters an artery, the symptoms are immediate: severe, sudden pain (which may radiate to the nose or forehead), immediate blanching (whitening) of the skin in the vascular territory, and any changes in vision (blurriness, double vision, or loss of sight). If any of these occur, the provider must immediately stop injecting and administer high-dose hyaluronidase.

How long does PRF take to show results compared to HA filler?

HA filler results are immediate. PRF results develop gradually over 2 to 3 months. While EZ Gel provides some immediate volume, this resolves within a week as the fluid is absorbed. The permanent thickening of the skin and tissue regeneration occur over several weeks as platelets release growth factors to build new collagen and blood vessels.

Does topical caffeine actually work, or is it just temporary?

Topical caffeine works, but its effects are strictly temporary. Caffeine is a vasoconstrictor; it temporarily constricts the superficial blood vessels under the eyes, reducing blue-purple discoloration and puffiness. These effects typically wear off within 4 to 8 hours.

---

Sources

1. Infraorbital Dark Circles: Pathogenesis, Evaluation, and Treatment (PMC4924417): https://pmc.ncbi.nlm.nih.gov/articles/PMC4924417/
2. Treatments of Infra-Orbital Dark Circles by Various Etiologies (PMC7992473): https://pmc.ncbi.nlm.nih.gov/articles/PMC7992473/
3. Dermatology Clinical Reference on Dark Circles: https://dermnetnz.org/topics/dark-circles-under-the-eyes
4. Mayo Clinic Guide to Under-Eye Dark Circles: https://www.mayoclinic.org/symptoms/dark-circles-under-eyes/in-depth/sym-20050624